Hybrid Delivery System Boosts DNA Vaccines Potential

Researchers at the University at Buffalo have developed a hybrid delivery system designed to fight cancer, HIV, flu, and other diseases Scientists from the University at Buffalo have created a novel hybrid system designed to deliver genetic antigens and elicit a strong immune response in patients, something DNA vaccines have so far failed to deliver. The hybrid, presented in the …

University of Buffalo Develops new transport System for DNA Vaccines for HIV, Malaria, HPV, and Other Major Illnesses

“By improving the delivery of DNA vaccines, we can potentially harness the human immune system in new ways to fight everything from the flu and herpes to HIV and cancer.” Blaine Pfeifer, associate professor, Department of Chemical and Biological Engineering November 25, 2014 Its performance isn’t measured by the distance it travels, but rather the delivery of its cargo: vaccines …

From Cedar and Peanut allergies to Cancer Vaccines and Immunotherapeutics: This is the future of DNA vaccine technology

One company stands on the brink of a revolution in vaccine technology that has the potential to change millions of lives with innovative DNA and RNA vaccines See the future of DNA vaccines: download the report For over 20 years the vaccines industry has pushed towards the goal of creating an effective DNA vaccine. But thus far the industry has …

This is the Future of the Vaccine Industry

  The vaccine business is changing. The vaccine industry is moving at a remarkable pace. And we here at Vaccine Nation have sought out the the leading minds within the vaccines industry to explain the challenges and opportunities we can expect in the future. Our experts from across the vaccines spectrum explain to us the mechanics behind the vaccine industry …

The Future of DNA Vaccines

In April 2013 over 500 delegates participated in the 13th Annual World Vaccine Congress Washington. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Tony Ford-Hutchinson, Merck entitle ‘The Future of DNA Vaccines' This presentation outlines: Vaccines Have Made a …

Promising data for DNA ‘reverse’ vaccine against Type 1 diabetes

A vaccine designed to combat type-1 diabetes mellitus (T1DM) has delivered promising results in a phase II clinical trial. Researchers at Stanford University School of Medicine trialled the DNA ‘reverse' vaccine in 80 patients with T1DM and taking insulin, and found that in the vaccine group, levels of C-peptide (a proxy of insulin production) were maintained or even occasionally increased …